» Articles » PMID: 26908331

Expression of the Innate Immune Receptor LILRB5 on Monocytes is Associated with Mycobacteria Exposure

Overview
Journal Sci Rep
Specialty Science
Date 2016 Feb 25
PMID 26908331
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Antigen presenting cells (APC) are critical components of innate immunity and consequently shape the adaptive response. Leukocyte Ig Like Receptors (LILR) are innate immune receptors predominantly expressed on myeloid cells. LILR can influence the antigen presenting phenotype of monocytic cells to determine the nature of T cell responses in infections including Mycobaterium leprae. We therefore investigated the relevance of LILR in the context of Mycobacterium tuberculosis. Real-time PCR studies indicated that the transcriptional profile of the orphan receptor LILRB5 was significantly up-regulated following exposure to mycobacteria. Furthermore, LILRA1 and LILRB5 were able to trigger signalling through direct engagement of mycobacteria using tranfectant cells incorporating a reporter system. We describe for the first time the expression of this receptor on T cells, and highlight the potential relevance to mycobacterial recognition. Furthermore, we demonstrate that crosslinking of this receptor on T cells increases proliferation of cytotoxic, but not helper, T cells.

Citing Articles

Smoking-Associated Changes in Gene Expression in Coronary Artery Disease Patients Using Matched Samples.

Merzah M, Poliska S, Balogh L, Sandor J, Fiatal S Curr Issues Mol Biol. 2024; 46(12):13893-13902.

PMID: 39727958 PMC: 11727024. DOI: 10.3390/cimb46120830.


Human leukocyte immunoglobulin-like receptors in health and disease.

Redondo-Garcia S, Barritt C, Papagregoriou C, Yeboah M, Frendeus B, Cragg M Front Immunol. 2023; 14:1282874.

PMID: 38022598 PMC: 10679719. DOI: 10.3389/fimmu.2023.1282874.


Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy.

Ridgley L, Caron J, Dalgleish A, Bodman-Smith M Front Immunol. 2023; 13:1065495.

PMID: 36713444 PMC: 9880221. DOI: 10.3389/fimmu.2022.1065495.


LILRB4, an immune checkpoint on myeloid cells.

Yang T, Qian Y, Liang X, Wu J, Zou M, Deng M Blood Sci. 2022; 4(2):49-56.

PMID: 35957669 PMC: 9362873. DOI: 10.1097/BS9.0000000000000109.


Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer.

Fan J, Wang L, Chen M, Zhang J, Li J, Song F World J Surg Oncol. 2022; 20(1):92.

PMID: 35321724 PMC: 8943947. DOI: 10.1186/s12957-022-02562-w.


References
1.
Jones D, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A . HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol. 2011; 186(5):2990-7. DOI: 10.4049/jimmunol.1003078. View

2.
Salem M . Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses. Immunol Lett. 2011; 137(1-2):9-14. DOI: 10.1016/j.imlet.2011.02.019. View

3.
Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J . A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1998; 186(11):1809-18. PMC: 2199153. DOI: 10.1084/jem.186.11.1809. View

4.
Pilsbury L, Allen R, Vordermeier M . Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection. Mediators Inflamm. 2010; 2010:536478. PMC: 2903975. DOI: 10.1155/2010/536478. View

5.
Huang J, Yang Y, Al-Mozaini M, Burke P, Beamon J, Carrington M . Dendritic cell dysfunction during primary HIV-1 infection. J Infect Dis. 2011; 204(10):1557-62. PMC: 3192192. DOI: 10.1093/infdis/jir616. View